高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

What are the review criteria for medical device registration with the US FDA?
Category：企業(yè)動態(tài) Date：2024-12-13 17:16:08 Author: Source:
The review criteria for medical device registration with the US FDA depend on the device classification (Class I, II, or III) and the type of submission (e.g., 510(k), Premarket Approval (PMA)). The main review criteria include:

The review criteria for medical device registration with the US FDA depend on the device classification (Class I, II, or III) and the type of submission (e.g., 510(k), Premarket Approval (PMA)). The main review criteria include:

1(3).jpg

  1. Device Classification and Risk Assessment:

    • The FDA evaluates the device's classification based on its intended use and potential risks. This determines whether the device requires a 510(k) submission, PMA, or is exempt from premarket submission.

  2. Substantial Equivalence (for 510(k) submissions):

    • For devices requiring a 510(k) submission, the FDA assesses whether the device is substantially equivalent to a legally marketed device (predicate device) in terms of safety and effectiveness.

  3. Safety and Effectiveness (for PMA submissions):

    • For Class III devices requiring PMA, the FDA requires evidence of the device's safety and effectiveness, typically through clinical trials and substantial scientific data.

  4. Compliance with FDA Regulations:

    • The device must comply with FDA regulations, including labeling requirements, Good Manufacturing Practices (GMP), and the Quality System Regulation (QSR) for manufacturing processes.

  5. Device Labeling and Instructions for Use (IFU):

    • The FDA evaluates the device's labeling to ensure that it provides clear, accurate, and adequate information for safe and effective use, including the intended use, indications, contraindications, and risks.

  6. Risk Management and Hazard Analysis:

    • The FDA reviews the manufacturer's risk management documentation, ensuring that a proper risk assessment (e.g., ISO 14971 compliance) has been conducted and that risks associated with the device are appropriately mitigated.

  7. Post-Market Surveillance and Reporting:

    • The FDA examines how the manufacturer plans to monitor the device post-market, including adverse event reporting and compliance with Medical Device Reporting (MDR) requirements.

  8. Clinical Data (if applicable):

    • For certain devices, the FDA may require clinical data to support claims of safety and effectiveness. This data is especially critical for PMA applications and high-risk devices.

  9. Environmental Impact (for certain devices):

    • The FDA may also review environmental impact considerations, particularly for devices that could pose significant environmental risks.

  10. Financial Disclosures:

  • In some cases, especially for PMA submissions, manufacturers may need to disclose financial information related to clinical trials, including conflicts of interest.

The FDA uses these criteria to ensure that medical devices are safe, effective, and manufactured according to the required standards before they are allowed to be marketed in the United States.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn